☆ 4.4 Letter

MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis

HAEMATOLOGICA (2015)

期刊

HAEMATOLOGICA

卷 100, 期 11, 页码 E471-E474

出版社

FERRATA STORTI FOUNDATION

DOI: 10.3324/haematol.2015.127001

关键词

t(4;14) translocation; heterogeneity; MB4 breakpoint; MMSET; prognostic factor

类别

Hematology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

Super Enhancer-Mediated Upregulation of HJURP Promotes Growth and Survival of t(4;14)-Positive

Yunlu Jia, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Yongxia Chen, Jing-Yuan Chooi, Takaomi Sanda, Melissa J. Fullwood, Sinan Xiong, Sabrina H. M. Toh, Kalpnaa Balan, Regina W. J. Wong, Julia S. L. Lim, Enfan Zhang, Zhen Cai, Peng Shen, Wee Joo Chng

Summary: The presence of super-enhancers in t(4;14) translocated multiple myeloma promotes the expression of HJURP through histone modification and transcriptional activation, leading to cell proliferation and apoptosis. This study introduces an efficient approach, SE profiling, to identify new targets and understand molecular pathogenesis in specific subtypes of cancer.

CANCER RESEARCH (2022)

添加到收藏夹

Article Hematology

Prognostic value of t(4;14) translocation in newly diagnosed multiple myeloma patients in novel agent era

Chuanying Geng, Guangzhong Yang, Huixing Zhou, Huijuan Wang, Yanchen Li, Yun Leng, Zhiyao Zhang, Yuan Jian, Wenming Chen

Summary: This study aimed to evaluate the prognostic value of t(4; 14) translocation for newly diagnosed multiple myeloma (MM) patients in the novel agent era. A retrospective analysis of 606 MM patients treated with novel agents was conducted. The results showed that t(4;14) alone may not be a poor prognostic factor for newly diagnosed MM patients in the novel agent era.

HEMATOLOGY (2023)

添加到收藏夹

Article Multidisciplinary Sciences

Mouse models of human multiple myeloma subgroups

Wiebke Winkler, Carlota Farre Diaz, Eric Blanc, Hanna Napieczynska, Patrick Langner, Marvin Werner, Barbara Walter, Brigitte Wollert-Wulf, Tomoharu Yasuda, Arnd Heuser, Dieter Beule, Stephan Mathas, Ioannis Anagnostopoulos, Andreas Rosenwald, Klaus Rajewsky, Martin Janz

Summary: By targeting the expression of genes involved in MM subgroup-specific chromosomal translocations into mouse GC B cells, we have generated distinct MM-like disease models that recapitulate key features of human tumors, which provides insights into the pathogenesis and therapeutic vulnerabilities of different MM subgroups.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

添加到收藏夹

Article Hematology

Clinical and prognostic significance of t(4;14) translocation in multiple myeloma in the era of novel agents

Shuku Sato, Wataru Kamata, Satomi Okada, Yotaro Tamai

Summary: Translocation t(4;14) is an independent prognostic factor associated with adverse outcomes in multiple myeloma, and it is specifically linked to the IgA isotype. Patients with t(4;14) have lower overall survival rates, although progression-free survival does not differ significantly.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)

添加到收藏夹

Article Oncology

Correlation of t(14;18) translocation breakpoint site with clinical characteristics in follicular lymphoma

Matej Panjan, Lucka Boltezar, Srdjan Novakovic, Ira Kokovic, Barbara Jezersek Novakovic

Summary: The objective of this study was to analyze the correlation between t(14;18)(q32;q21) breakpoint site and clinical characteristics in follicular lymphoma. The results showed that patients with MBR breakpoint had more favorable clinical characteristics compared to those with mcr breakpoint.

RADIOLOGY AND ONCOLOGY (2023)

添加到收藏夹

Article Medicine, General & Internal

Analysis of 2 men with t(8;22)(q13;q13) and t(8;14)(q13;q22) chromosomal translocation karyotypes

Qijia Sun, Xiaoyu Zhang, Peng Zhan, Wenjie Tian, Yanli Wang, Xiao Yang

Summary: Male infertility is closely associated with chromosomal abnormalities, including reciprocal chromosomal translocation (RCT). RCT can disrupt the structure and function of genes responsible for spermatogenesis, leading to male infertility. This study describes two male carriers of RCTs and investigates the relationship between RCT breakpoints and male infertility. The results suggest that physicians should consider the clinical phenotype and RCT breakpoints in genetic counseling, and further research is needed on a gene located in the chromosome region 22q13 related to male infertility.

MEDICINE (2022)

添加到收藏夹

Article Plant Sciences

Location of Tandem Repeats on Wheat Chromosome 5B and the Breakpoint on the 5BS Arm in Wheat Translocation T7BS.7BL-5BS Using Single-Copy FISH Analysis

Wei Zhang, Zongxiang Tang, Jie Luo, Guangrong Li, Zujun Yang, Manyu Yang, Ennian Yang, Shulan Fu

Summary: This study identified the clustering regions of two important tandem repeats on wheat chromosome 5B by analyzing the wheat genome sequence. Additionally, the sequence characteristics of the translocation breakpoint of the translocation T7BS.7BL-5BS were discovered. These findings have significant implications for future research and improvement of the wheat genome.

PLANTS-BASEL (2022)

添加到收藏夹

Article Medicine, General & Internal

Fertility problems in men carrying a translocation involved in breakpoints on chromosome 17p13: A retrospective, observational study

Ranwei Li

Summary: This study aimed to identify the clinical features of 3 men with translocation karyotypes involving breakpoints on chromosome 17p13. The results suggest that although chromosome 17 is closely related to spermatogenic failure, the clinical phenotypes of RCT carriers with involvement of 17p13 breakpoints are varied. The important genes involved in the breakpoint were analyzed, and the results suggested that these target genes on chromosome band 17p13 were mostly involved in microfilament motor activity, ATPase activity.

MEDICINE (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Identification of NRF2 Activation as a Prognostic Biomarker in T-Cell Acute Lymphoblastic Leukaemia

Maria Villa-Morales, Laura Perez-Gomez, Eduardo Perez-Gomez, Pilar Lopez-Nieva, Pablo Fernandez-Navarro, Javier Santos

Summary: The standard-of-care treatment for T-cell acute lymphoblastic leukaemia (T-ALL) achieves reasonable response rates, but relapsed or treatment-resistant patients have poor outcomes. This study explores the potential of NRF2 activation as a prognostic biomarker in T-ALL. Through analysis of transcriptomic, genomic, and clinical data, high NFE2L2 levels were found to be associated with shorter overall survival in T-ALL patients. The PI3K-AKT-mTOR pathway plays a role in the oncogenic signaling induced by NRF2 in T-ALL. High NFE2L2 levels are also associated with drug resistance in T-ALL, possibly due to NRF2-induced glutathione biosynthesis. These findings suggest that NFE2L2 levels could be a predictive biomarker for poor treatment response in T-ALL patients, offering insights for improved patient stratification and targeted therapies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

添加到收藏夹

Article Plant Sciences

A rhomboid-like protease gene from an interspecies translocation confers resistance to cyst nematodes

Avneesh Kumar, Hans-Joachim Harloff, Siegbert Melzer, Johanna Leineweber, Birgit Defant, Christian Jung

Summary: A study identified a nematode-resistant gene Hs4, introduced into the beet genome via translocations, playing a crucial role in nematode control. The encoded protease, predicted to be bound to the endoplasmic reticulum, contributes to resistance as knockout results in complete loss and overexpression causes resistance.

NEW PHYTOLOGIST (2021)

添加到收藏夹

Article Environmental Sciences

Tolerance of cotton to elevated levels of Pb and its potential for phytoremediation

Sivakoti Ramana, Awadhesh Kumar Tripathi, Kollah Bharati, Amar Bahadur Singh, Ajay Kumar, Asha Sahu, Poonam Singh Rajput, Pradip Dey, Jayanta Kumar Saha, Ashok K. Patra

Summary: The study found that cotton plants have a certain tolerance to lead, but are not suitable as hyperaccumulators of lead. They mainly use an exclusion mechanism to cope with lead stress, and have very low bioconcentration and translocation efficiency for lead.

ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Epigenomic reprogramming via HRP2-MINA dictates response to proteasome inhibitors in multiple myeloma with t(4;14) translocation

Jingjing Wang, Xu Zhu, Lin Dang, Hongmei Jiang, Ying Xie, Xin Li, Jing Guo, Yixuan Wang, Ziyi Peng, Mengqi Wang, Jingya Wang, Sheng Wang, Qian Li, Yafei Wang, Qiang Wang, Lingqun Ye, Lirong Zhang, Zhiqiang Liu

Summary: The t(4;14) chromosomal translocation drives high expression of NSD2 and plays important roles in MM evolution and progression. HRP2 downregulation is associated with poor response and worse outcomes in PIs treatment, and its suppression promotes cell survival and restricts ER stress by increasing H3K27me3 levels.

JOURNAL OF CLINICAL INVESTIGATION (2022)

添加到收藏夹

Article Oncology

Investigation of the effects of overexpression of jumping translocation breakpoint (JTB) protein in MCF7 cells for potential use as a biomarker in breast cancer

Madhuri Jayathirtha, Anca-Narcisa Neagu, Danielle Whitham, Shelby Alwine, Costel C. Darie

Summary: JTB gene plays a dual role as a tumor suppressor or oncogene in different malignancies, including breast cancer, where it is overexpressed. The study aims to decipher the molecular functions and biological processes through which JTB protein promotes increased cell growth, proliferation, and invasion in breast cancer. By using cellular proteomics approaches, the research identified dysregulation patterns of various proteins associated with JTB upregulation, shedding light on its contribution to tumorigenesis and potential therapeutic targets.

AMERICAN JOURNAL OF CANCER RESEARCH (2022)

添加到收藏夹

Article Oncology

Investigation of the effects of downregulation of jumping translocation breakpoint (JTB) protein expression in MCF7 cells for potential use as a biomarker in breast cancer

Madhuri Jayathirtha, Anca-Narcisa Neagu, Danielle Whitham, Shelby Alwine, Costel C. Darie

Summary: This study explores the potential functions of the JTB protein and finds that downregulation of the JTB protein leads to increased invasiveness in the MCF7 cell line. Proteomic analysis reveals that most of the upregulated proteins promote actin cytoskeleton reorganization and are involved in EMT, energy metabolism reprogramming, stress response, and immune and inflammatory response. The downregulated proteins function in suppression of cancer cell growth, invasion, EMT, tumorigenic abilities, glucose and lipid metabolism, nuclear envelope stability disruption, apoptosis suppression, and anti-angiogenetic activities.

AMERICAN JOURNAL OF CANCER RESEARCH (2022)

添加到收藏夹

Article Endocrinology & Metabolism

Obesity accelerates acute promyelocytic leukemia in mice and reduces sex differences in latency and penetrance

John W. R. Kincaid, Gretchen Weiss, Anne E. Hill-Baskin, Heidi M. Schmidt, Ovwoioise Omoijuanfo, Cheryl L. Thompson, Rose C. Beck, Nathan A. Berger

Summary: Obesity and diet can promote the development of acute promyelocytic leukemia (APL), reducing the impact of gender differences in disease latency and penetrance.

OBESITY (2022)

添加到收藏夹

Article Hematology

APR-246 induces early cell death by ferroptosis in acute myeloid leukemia

Rudy Birsen, Clement Larrue, Justine Decroocq, Natacha Johnson, Nathan Guiraud, Mathilde Gotanegre, Lilia Cantero-Aguilar, Eric Grignano, Tony Huynh, Michaela Fontenay, Olivier Kosmider, Patrick Mayeux, Nicolas Chapuis, Jean Emmanuel Sarry, Jerome Tamburini, Didier Bouscary

Summary: APR 246 is a promising therapeutic agent for myelodysplastic syndromes and acute myeloid leukemia that targets p53 mutated proteins. It has been found to reactivate the transcriptional activity of p53 mutants and induce p53-independent cell death. The study also demonstrates the association between APR 246 and ferroptosis, a recently described cell death process. The detoxification capacity of AML cells to maintain glutathione biosynthesis may play a key role in determining sensitivity to APR 246.

HAEMATOLOGICA (2022)

添加到收藏夹

Article Oncology

An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML

Shan Lin, Clement Larrue, Nastassja K. Scheidegger, Bo Kyung A. Seong, Neekesh Dharia, Miljan Kuljanin, Caroline S. Wechsler, Guillaume Kugener, Amanda L. Robichaud, Amy Saur Conway, Thelma Mashaka, Sarah Mouche, Biniam Adane, Jeremy A. Ryan, Joseph D. Mancias, Scott T. Younger, Federica Piccioni, Lynn H. Lee, Mark Wunderlich, Anthony Letai, Jerome Tamburini, Kimberly Stegmaier

Summary: This study utilized CRISPR screening to identify and validate AML-specific dependencies in vivo, including metabolic vulnerability and apoptosis regulator, providing an important strategy for discovering and prioritizing AML therapeutic targets.

CANCER DISCOVERY (2022)

添加到收藏夹

Article Hematology

Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against alpha and delta variants in patients with multiple myeloma

Soledad Henriquez, Jeremie Zerbit, Timothee Bruel, Amani Ouedrani, Delphine Planas, Paul Deschamps, Isabelle Staropoli, Jerome Hadjadj, Bruno Varet, Natalia Ermak, Didier Bouscary, Lise Willems, Guillemette Fouquet, Justine Decroocq, Patricia Franchi, Benedicte Deau-Fischer, Benjamin Terrier, Jerome Tamburini, Lucienne Chatenoud, Olivier Schwartz, Marguerite Vignon

BLOOD (2022)

添加到收藏夹

Letter Hematology

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study

Amira Marouf, Anne Segolene Cottereau, Salim Kanoun, Paul Deschamps, Michel Meignan, Patricia Franchi, David Sibon, Clara Antoine, Thomas Gastinne, Cecile Borel, Mohammad Hammoud, Guillaume Sicard, Romane Gille, Doriane Cavalieri, Aspasia Stamatoullas, Lauriane Filliatre-Clement, Julien Lazarovici, Adrien Chauchet, Luc-Matthieu Fornecker, Sandy Amorin, Mathieu Rocquet, Nicole Raus, Barbara Burroni, Marie Therese Rubio, Didier Bouscary, Philippe Quittet, Rene Olivier Casasnovas, Pauline Brice, Herve Ghesquieres, Jerome Tamburini, Benedicte Deau

HAEMATOLOGICA (2022)

添加到收藏夹

Article Cell Biology

AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia

Adrien Grenier, Laury Poulain, Johanna Mondesir, Arnaud Jacquel, Claudie Bosc, Lucille Stuani, Sarah Mouche, Clement Larrue, Ambrine Sahal, Rudy Birsen, Victoria Ghesquier, Justine Decroocq, Fetta Mazed, Mireille Lambert, Mamy Andrianteranagna, Benoit Viollet, Patrick Auberger, Andrew A. Lane, Pierre Sujobert, Didier Bouscary, Jean-Emmanuel Sarry, Jerome Tamburini

Summary: AMPK activation in AML cells triggers the unfolded protein response, leading to repression of oxidative phosphorylation, TCA cycle, and pyrimidine biosynthesis, as well as enhanced mitochondrial apoptotic signaling. Combination therapy with the AMPK activator GSK621 and the Bcl-2 inhibitor venetoclax shows synergistic effects, suggesting therapeutic potential in AML.

CELL REPORTS (2022)

添加到收藏夹

Letter Oncology

A Phase II prospective trial of azacitidine in steroid-dependent or refractory systemic autoimmune/inflammatory disorders and VEXAS syndrome associated with MDS and CMML

Arsene Mekinian, Lin Pierre Zhao, Sylvie Chevret, Kristell Desseaux, Laurent Pascal, Thibaut Comont, Alexandre Maria, Pierre Peterlin, Louis Terriou, Maud D'Aveni Piney, Marie-Pierre Gourin, Norbert Vey, Odile Beyne Rauzy, Vincent Grobost, Holy Bezanahary, Sophie Dimicoli-Salazar, Anne Banos, Stefan Wickenhauser, Benoit De Renzis, Eric Durot, Shanti Natarajan-Ame, Laurent Voillat, Fatiha Chermat, Karine Lemaire, Vincent Jachiet, Chantal Himberlin, Sylvain Thepot, Jose Miguel Torregrosa Diaz, Laurent Frenzel, Emmanuel Gyan, Guillaume Denis, Pierre Hirsch, Olivier Kosmider, Lionel Ades, Olivier Fain, Pierre Fenaux

LEUKEMIA (2022)

添加到收藏夹

Article Oncology

Mitochondrial fusion is a therapeutic vulnerability of acute myeloid leukemia

Clement Larrue, Sarah Mouche, Shan Lin, Federico Simonetta, Nastassja K. Scheidegger, Laury Poulain, Rudy Birsen, Jean-Emmanuel Sarry, Kimberly Stegmaier, Jerome Tamburini

Summary: Mitochondrial fusion is a critical dependency in acute myeloid leukemia (AML). Inhibition of mitochondrial fusion through genetic depletion or pharmacological inhibition showed significant anti-leukemic activity in patient-derived xenograft (PDX) models, without impacting normal hematopoietic cells. Mechanistically, disruption of mitochondrial fusion led to cell cycle arrest and impaired mitochondrial respiration and reactive oxygen species production. These findings suggest that inhibition of mitochondrial fusion holds promise as a therapeutic approach for AML.

LEUKEMIA (2023)

添加到收藏夹

Article Hematology

Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study

J. Dufour, S. Choquet, K. Hoang-Xuan, A. Schmitt, G. Ahle, R. Houot, L. Taillandier, R. Gressin, O. Casasnovas, J. P. Marolleau, J. Tamburini, C. Serrier, E. Perez, J. Paillassa, E. Gyan, A. Chauchet, R. Ursu, A. Kas, C. Soussain, C. Houillier

Summary: This nationwide population-based study found rare extracerebral relapses of primary central nervous system lymphomas (PCNSL). The extracerebral relapses were mainly found in visceral organs (particularly testis and breast) and the peripheral nervous system. The prognosis was worse for mixed relapses. The study suggests the use of PET-CT in diagnosis and paired tumor analysis at diagnosis/relapse to better understand the underlying molecular mechanisms.

ANNALS OF HEMATOLOGY (2023)

添加到收藏夹

Article Hematology

Tandem haematopoietic stem cell transplantation versus single cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA

A. Marouf, N. Molinari, D. Sibon, A. S. Cottereau, S. Kanoun, C. Antoine, P. E. Debureaux, D. Cavalieri, L. M. Fornecker, R. O. Casasnovas, C. Herbaux, S. Amorim, C. Rossi, D. Bouscary, P. Brice, H. Ghesquieres, J. Tamburini, B. Deau

Summary: Autologous hematopoietic stem cell transplant (ASCT) is the standard curative treatment for high-risk relapsed/refractory Hodgkin lymphoma (R/R HL) patients. Maintenance therapy with Brentuximab Vedotin (BV) after ASCT has been shown to improve survival in BV-naive patients. In this study, BV maintenance was compared to tandem transplant strategies and was found to be associated with better survival outcomes in patients with high-risk R/R HL.

BRITISH JOURNAL OF HAEMATOLOGY (2023)

添加到收藏夹

Article Hematology

Matching-adjusted indirect comparison of bleeding outcomes in severe haemophilia A: Comparing valoctocogene roxaparvovec gene therapy, emicizumab prophylaxis, and FVIII replacement prophylaxis

Jan Astermark, Tyler W. Buckner, Laurent Frenzel, Anthony J. Hatswell, Xiaojun You, Hai Liu, Erin Goodman, Sandra Santos, Charles Hawes, David Hinds, Robert Klamroth

Summary: This study indirectly compared the bleeding rates between valoctocogene roxaparvovec and emicizumab, two treatments for haemophilia A. The results showed that valoctocogene roxaparvovec had lower bleeding rates and higher proportions of participants with no joint bleeds compared to emicizumab. Emicizumab was also more effective than FVIII prophylaxis regimens.

HAEMOPHILIA (2023)

添加到收藏夹

Article Oncology

C/EBP & alpha; Confers Dependence to Fatty Acid Anabolic Pathways and Vulnerability to Lipid Oxidative Stress-Induced Ferroptosis in FLT3-Mutant Leukemia

Marie Sabatier, Rudy Birsen, Laura Lauture, Sarah Mouche, Paolo Angelino, Jonas Dehairs, Ismael Boussaid, Mael Heiblig, Emeline Boet, Ambrine Sahal, Estelle Saland, Juliana C. Santos, Marc Armengol, Miranda Fernandez-Serrano, Thomas Farge, Guillaume Cognet, Federico Simonetta, Corentin Pignon, Antoine Graffeuil, Celine Mazzotti, Herve Avet-Loiseau, Oceane Delos, Justine Bertrand-Michel, Amelie Chedru, Vilma Dembitz, Paolo Gallipoli, Natasha S. Anstee, Sun Loo, Andrew H. Wei, Martin Carroll, Armelle Goubard, Remy Castellano, Yves Collette, Francois Vergez, Veronique Mansat-De Mas, Sarah Bertoli, Suzanne Tavitian, Muriel Picard, Christian Recher, Nathalie Bourges-Abella, Fanny Granat, Olivier Kosmider, Pierre Sujobert, Benoit Colsch, Carine Joffre, Lucille Stuani, Johannes V. Swinnen, Herve Guillou, Gael Roue, Nawad Hakim, Anne S. Dejean, Petros Tsantoulis, Clement Larrue, Didier Bouscary, Jerome Tamburini, Jean-Emmanuel Sarry

Summary: Although the role of CCAAT-enhancer binding protein α (C/EBPα) in cancer cell and metabolic homeostasis is largely unknown, this study reveals its coordination with FLT3 in lipid anabolism and its regulation of fatty acid biosynthesis and desaturation. Furthermore, FLT3 or C/EBPα inactivation decreases monounsaturated fatty acid incorporation and renders FLT3-mutant AML cells vulnerable to ferroptosis. This finding suggests a promising therapeutic potential for targeting FLT3-mutant AML cells.

CANCER DISCOVERY (2023)

添加到收藏夹

Letter Hematology

Clinico-biological features, treatment and prognosis of primary myeloid sarcoma: A French retrospective multi-centric observational study

Maya Belhadj, Barbara Burroni, Olivier Kosmider, Lise Willems, Marie Temple, Sarah Bertoli, Corentin Orvain, Pierre-Yves Dumas, Celine Berthon, Ludovic Gabellier, Ambroise Marcais, Emmanuel Raffoux, Cecile Pautas, Alexis Genthon, Justine Decroocq, Rudy Birsen, Jerome Tamburini, Didier Bouscary, Adrien Contejean

BRITISH JOURNAL OF HAEMATOLOGY (2023)

添加到收藏夹

Letter Hematology

Interferences by factor VIII and lupus anticoagulant in the modified one-stage assay for emicizumab

Capucine Habay, Claire Auditeau, Adeline Blandinieres, Nun K. Bentounes, Cecile Lavenu-Bombled, Annie Harroche, Cecile Bally, Laurent Frenzel, Delphine Borgel, Dominique Lasne

HAEMOPHILIA (2023)

添加到收藏夹

Meeting Abstract Oncology

Time to response, duration of response, and patient-reported outcomes (PROs) with daratumumab (DARA) plus lenalidomide and dexamethasone (D-Rd) versus lenalidomide and dexamethasone (Rd) alone in transplant-ineligible patients with newly diagnosed multiple myeloma (NDMM): Subgroup analysis of the phase 3 MAIA study.

Thierry Facon, Shaji Kumar, Torben Plesner, Philippe Moreau, Nizar J. Bahlis, Hartmut Goldschmidt, Michael O'Dwyer, Aurore Perrot, Christopher, P. Venner, Katja Weisel, Joseph R. Mace, Noopur S. Raje, Mourad Tiab, Margaret Macro, Laurent Frenzel, Xavier Leleu, Huiling Pei, Fredrik Borgsten, Saad Zafar Usmani

JOURNAL OF CLINICAL ONCOLOGY (2022)

添加到收藏夹

Meeting Abstract Hematology

Afath webinars: An illustration of partnership in care model

Thomas Sannie, Jean-Paul Ngoukoulou, Laurent Frenzel, Mamady Diakite, Claire Pouplard, Tatiana Baglo, Anne Ryman, Claire Arce, Philippe de Moerloose

HAEMOPHILIA (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.